Publications by authors named "Jane Loong"

Claim this Profile
R
Retroelement co-option disrupts the cancer transcriptional programme.
Jane Loong, Rachael Thompson, Callum Hall, Laura Doglio, Judith Pape

Genome Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct ontogenetic lineages dictate cDC2 heterogeneity.
Carlos M Minutti, Cécile Piot, Mariana Pereira da Costa, Probir Chakravarty, Neil Rogers, Jane Loong

Nat Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SERPINA12 promotes the tumorigenic capacity of HCC stem cells through hyperactivation of AKT/β-catenin signaling.
Huajian Yu, Lei Zhou, Jane H C Loong, Ka-Hei Lam, Tin-Lok Wong

Hepatology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The transcriptional landscape of endogenous retroelements delineates esophageal adenocarcinoma subtypes.
Anastasiya Kazachenka, Jane Hc Loong, Jan Attig, George R Young, Piyali Ganguli

NAR Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progression.
Lei Zhou, Ken Ho Yu, Tin Lok Wong, Zhao Zhang, Chun Ho Chan, Jane Hc Loong

Gut· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose deprivation-induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma.
Jane Hc Loong, Tin-Lok Wong, Man Tong, Rakesh Sharma, Lei Zhou

J Clin Invest· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate.
Fan-En Kong, Guang-Meng Li, Yun-Qiang Tang, Shao-Yan Xi, Jane Ho Chun Loong

Sci Transl Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma.
Xiao-Dong Yang, Fan-En Kong, Ling Qi, Jia-Xin Lin, Qian Yan, Jane Ho Chun Loong

Mol Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.
Ming Liu, Qian Yan, Yi Sun, Yoonhee Nam, Liang Hu, Jane Hc Loong

Proc Natl Acad Sci U S A· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation.
Lok Hei Chan, Lei Zhou, Kai Yu Ng, Tin Lok Wong, Terence K Lee, Jane H Loong

Cell Rep· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis